Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OPRX
#3141
OptimizeRx Corporation Common Stock
7.5
8
-2.82%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
-2.82%
Месячное изменение
-35.82%
6-месячное изменение
-56.78%
Годовое изменение
+46.05%
Предыдущее закрытие
7.8
0
Open
7.5
8
Bid
Ask
Low
7.5
8
High
7.5
8
Объем
33
Рынки
Рынок акций США
Здравоохранение
OPRX
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
16.81 M
17.88 M
17.1 M
18.18 M
18.49 M
—
Valuation ratios
Enterprise value
513.18 M
1.03 B
274.54 M
241.45 M
76.48 M
816.74 M
Price to earnings ratio
207.73
3 105.5
-26.75
-13.63
-4.42
-184.65 P
Price to sales ratio
10.67
17.93
4.88
3.36
0.97
8.55
Price to cash flow ratio
73.22
1 513.36
28.58
-33.21
18.18
99.24
Price to book ratio
9.25
8.36
2.41
1.9
0.76
2.45
Enterprise value to EBITDA ratio
-3 124.66
440.83
-26.74
-10.06
-8.95
153.31
Profitability ratios
Return on assets %
0.04
0
-0.08
-0.1
0.12
0.03
Return on equity %
0.04
0
-0.09
-0.14
0.17
0.04
Return on invested capital %
20.77
2.9
-90.08
-68.54
34.42
14.43
Gross margin %
55.65
58.14
62.4
59.98
64.45
260.03
Operating margin %
4.93
0.59
-19.68
-36.91
14.88
17.18
EBITDA margin %
-0.38
3.8
-16.44
-33.56
-9.27
37.29
Net margin %
5.1
0.62
-18.32
-24.56
21.83
18.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.28
12.29
11.74
3.04
2.89
11.33
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.74
0.61
0.45
0.45
0.52
0.65
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.19
0.18
0.65
Long term debt to total equity ratio
—
—
—
0.27
0.26
0.93
Per share metrics
Operating cash flow per share
0.43
0.04
0.6
-0.42
0.27
0.62
EBIT per share
-0.14
0.02
-0.69
-1.54
-0.75
0.36
EBITDA per share
-0.01
0.13
-0.58
-1.4
-0.47
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
0.71
4.79
4.17
0.81
0.73
4.84
Net current asset value per share
2.22
6.51
5.54
3.17
2.95
11.49
Tangible book value per share
1.56
5.99
5.39
-1.7
0.03
9.35
Working capital per share
1.54
5.98
5.07
2.13
1.93
7.42
Book value per share
3.37
7.43
7.09
7.39
6.4
25.25
Новости
Intuit (INTU) Q2 Earnings and Revenues Top Estimates
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript
OptimizeRx превзошла ожидания по прибыли в 3 квартале 2025 года
Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates
OPTIMIZERx earnings beat by $0.16, revenue topped estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Целевая цена OptimizeRX повышена до $23 с $20 в Citizens
OptimizeRX price target raised to $23 from $20 at Citizens